LJI308

CAS No. 1627709-94-7

LJI308 ( LJI308; LJI-308; LJI 308; NVP-LJI308; NVP-LJI-308 )

Catalog No. M17345 CAS No. 1627709-94-7

LJI308 is a potent, and pan-RSK (p90 ribosomal S6 kinase) inhibitor with IC50 of 6 nM, 4 nM, and 13 nM for RSK1, RSK2, and RSK3, respectively.

Purity : 98%

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 73 In Stock
10MG 88 In Stock
25MG 203 In Stock
50MG 316 In Stock
100MG 486 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    LJI308
  • Note
    Research use only, not for human use.
  • Brief Description
    LJI308 is a potent, and pan-RSK (p90 ribosomal S6 kinase) inhibitor with IC50 of 6 nM, 4 nM, and 13 nM for RSK1, RSK2, and RSK3, respectively.
  • Description
    LJI308 is a RSK inhibitor. LJI308 overcomes chemoresistance by eliminating cancer stem cells. LJI308 targets the CSC population and repress TNBC growth and dissemination. LJI308 specifically targeted transformed cells as it had little effect on the non-tumorigenic parental HMECs. Targeting RSK using specific and potent inhibitors, such as LJI308, delivers the promise of inhibiting the growth of TNBC.
  • Synonyms
    LJI308; LJI-308; LJI 308; NVP-LJI308; NVP-LJI-308
  • Pathway
    Angiogenesis
  • Target
    PDE
  • Recptor
    RSK1;RSK2;RSK3
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    1627709-94-7
  • Formula Weight
    368.38
  • Molecular Formula
    C21H18F2N2O2
  • Purity
    98%
  • Solubility
    DMSO : ≥ 32 mg/mL 86.87 mM
  • SMILES
    Oc1c(F)cc(cc1F)-c1cnccc1-c1ccc(cc1)N1CCOCC1
  • Chemical Name
    2,6-Difluoro-4-[4-[4-(4-morpholinyl)phenyl]-3-pyridinyl]-phenol

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Aronchik I, Appleton B A, Basham S E, et al. Molecular Cancer Research, 2014, 12(5): 803-812.
molnova catalog
related products
  • BI-409306

    BI-409306 is a potent and selective inhibitor of PDE9A (IC50 of 52 nM),and can be used in the research of memory.

  • GEBR-7b

    GEBR-7b is a phosphodiesterase-4 (PDE4) inhibitor.

  • GSK 356278

    A potent, selective, brain-penetrant and orally bioavailable phosphodiesterase 4 (PDE4) inhibitor with pIC50 of 8.8 (PDE4B); equally inhibits PDE4A and PDE4Dwith pIC50 of 8.6 and 8.7.